Richard H. Creech
64 works · 16,496 citations · h-index 28
Top works
- Toxicity and response criteria of the Eastern Cooperative Oncology Group
- Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
- Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.
- A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma
- Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
- Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
- An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer
- “The state of the art” toward defining the role of radiation therapy in the management of small cell bronchogenic carcinoma
- Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
- Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin
- Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.
- Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
- An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients
- Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).
- A comparative clinical trial of adriamycin and 5‐fluorouracil in advanced prostatic cancer: Prognostic factors and response
- A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study
- Breast cancer without axillary metastases. Are there high-risk biologic subpopulations?
- Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small cell lung carcinoma (EST-2575, generation I).
- Scan detection of bone marrow infarcts in sickle cell disorders.